IP Library Granted Patent US 10,856,546
Granted Patent B2
US 10,856,546 · App. 14/872,298 · Granted Dec 8, 2020

Hypersensitive response elicitor peptides and use thereof

Inventors: Zhongmin Wei (Kirkland, WA); Gregory A. Zornetzer (Seattle, WA); Stephen Bornick (Raleigh, NC)
Assignee: PLANT HEALTH CARE, INC.
A01N37/46A01N25/02A01N25/12A01N37/22A01N43/36A01N43/54A01N43/90A01N47/44A01N51/00A01N63/00A01N63/10C07K7/08C07K14/001C07K14/195C07K14/24C07K14/27C07K14/415C12N15/8279C12N15/8283C07K2319/00C07K2319/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,856,546
App. No.
14/872,298
Granted
Dec 8, 2020
Kind
B2
Abstract

Disclosed are hypersensitive-response eliciting peptides that exhibit improved solubility, stability, resistance to chemical degradation, or a combination of these properties. Use of these peptides or fusion polypeptides, or DNA constructs encoding the same, for modulating plant biochemical signaling, imparting disease resistance to plants, enhancing plant growth, imparting tolerance to biotic stress, imparting tolerance and resistance to abiotic stress, imparting desiccation resistance to cuttings removed from ornamental plants, imparting post-harvest disease or post-harvest desiccation resistance to a fruit or vegetable, or enhancing the longevity of fruit or vegetable ripeness are also disclosed.

Claims (34)

1. An isolated peptide that is up to 50 amino acids in length and, when introduced onto mechanically wounded plant leaf tissue, induces a hypersensitive response in the mechanically wounded plant leaf tissue, the isolated peptide comprising:

(a) the amino acid sequence of one of SEQ ID NOS: 6-11, 19, 20, 22-24, 27-30, 32, 34, 37, 40-46, 98, 107-125, 127-131, 136-139, 191, and 196; or

(b) a variant of the amino acid sequence of one of SEQ ID NOS: 6-11, 19, 20, 22-24, 27-30, 32, 34, 37, 40-46, 98, 107-125, 127-131, 136-139, 191, and 196 except that (i) all lysine and arginine residues are changed to glutamate and (ii) an arginine residue is introduced at the C-terminal end of the peptide.

2. The isolated peptide according to claim 1 , wherein said peptide consists of the amino acid sequence of one of SEQ ID NOS: 6-11, 19, 20, 22-24, 27-30, 32, 34, 37, 40, 98, 107, 108, 111-114, 116, 117, 119-125, 127-131, 136-139, 191, and 196.

3. The isolated peptide according to claim 1 , wherein said peptide consists of the amino acid sequence of one of SEQ ID NOS: 41-46, 109, 110, 115, and 118.

4. The isolated peptide according to claim 1 , wherein the peptide comprises the amino acid sequence of one of SEQ ID NOS: 6-11, 19, 20, 22-24, 27-30, 32, 34, 37, 40, 98, 107, 108, 111-114, 116, 117, 119-125, 127-131, 136-139, 191, and 196.

5. The isolated peptide according to claim 1 , wherein the peptide comprises the amino acid sequence of one of SEQ ID NOS: 41-46, 109, 110, 115, and 118.

6. The isolated peptide according to claim 1 , wherein the peptide is at least 90% pure.

7. The isolated peptide according to claim 1 , wherein the peptide is a fusion polypeptide further comprising a second amino acid sequence.

8. The isolated peptide according to claim 7 , wherein the second amino acid sequence includes a purification tag.

9. The isolated peptide according to claim 8 , wherein the second amino acid sequence further includes a cleavable linker sequence between the purification tag and the amino acid sequence.

10. The isolated peptide according to claim 7 , wherein the peptide is a fusion polypeptide comprising two copies of said peptide.

11. A fusion polypeptide comprising a plurality of amino acid sequences linked together in series, each of the plurality of amino acid sequences comprising a peptide according to claim 1 .

12. A composition comprising one or more peptides according to claim 1 , and a carrier.

13. The composition according to claim 12 , wherein the composition is a clarified cell extract.

14. The composition according to claim 12 further comprising an additive selected from the group consisting of fertilizer, herbicide, insecticide, fungicide, nematicide, a bactericidal agent, a biological inoculant, a plant regulator, and mixtures thereof.

15. The composition according to claim 14 , wherein the composition further comprises:

clothianidin, a combination of clothianidin and Bacillus firmus , imidicloprid, or a combination of imidicloprid and Bacillus firmus.

16. The composition according to claim 14 , wherein the composition further comprises:

thiamethoxam; a combination of thiamethoxam, mefenoxam, and fludioxynil; a combination of thiamethoxam, mefenoxam, fludioxynil and azoxystrobin; a combination of thiamethoxam and abamectin; a combination of thiamethoxam, abamectin, and a Pasteuria nematicide; or a combination of thiamethoxam, mefenoxam, fludioxynil, azoxystrobin, thiabendazole, and abamectin.

17. The composition according to claim 14 , wherein the composition further comprises:

a biological inoculant comprising a Bradyrhizobium spp., a Bacillus spp., and a combination thereof.

18. The composition according to claim 12 , wherein the carrier is an aqueous carrier.

19. The composition according to claim 18 , wherein the aqueous carrier further comprises one or more of a biocidal agent, a protease inhibitor, a non-ionic surfactant, or a combination thereof.

20. The composition according to claim 12 , wherein the carrier is a solid carrier in particulate form.

21. The composition according to claim 20 , wherein the solid carrier is a dry powder.

22. A method of imparting disease resistance to plants comprising:

applying an effective amount of an isolated peptide according to claim 1 to a plant or plant seed or the locus where the plant is growing or is expected to grow, wherein said applying is effective to impart disease resistance.

23. A method of enhancing plant growth comprising:

applying an effective amount of an isolated peptide according to claim 1 to a plant or plant seed or the locus where the plant is growing or is expected to grow, wherein said applying is effective to enhance plant growth.

24. A method of increasing a plant's tolerance to biotic stress comprising:

applying an effective amount of an isolated peptide according to claim 1 to a plant or plant seed or the locus where the plant is growing or is expected to grow, wherein said applying is effective to increase the plant's tolerance to biotic stress factors selected from the group consisting of insects, arachnids, nematodes, weeds, and combinations thereof.

25. A method of increasing a plant's tolerance to abiotic stress comprising:

applying an effective amount of an isolated peptide according to claim 1 to a plant or plant seed or the locus where the plant is growing or is expected to grow, wherein said applying is effective to increase the plant's tolerance to abiotic stress factors selected from the group consisting of salt stress, water stress, ozone stress, heavy metal stress, cold stress, heat stress, nutritional stress, and combinations thereof.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 73971 FRAME: 29. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 5, 2026
From: PLANT HEALTH CARE, INC.
To: PI AGSCIENCES, INC.
Reel/Frame 075041/0760 →
CHANGE OF NAME Recorded Dec 19, 2025
From: PLANT HEALTH CARE, INC.
To: PI AGSCIENCES, INC.
Reel/Frame 073971/0029 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2016
From: WEI, ZHONGMIN; ZORNETZER, GREGORY A.; BORNICK, STEPHEN
To: PLANT HEALTH CARE, INC.
Reel/Frame 038003/0840 →
Continuity (4)
Provisional Application 62140789 · Mar 31, 2015
Provisional Application 62058535 · Oct 1, 2014
Related Publication 20160095314A1 · Apr 7, 2016
Related Publication 20170156322A9 · Jun 8, 2017